EP 3397266 A1 20181107 - FACTOR H FRAGMENT FOR USE AS AN ANTI-ANGIOGENIC AGENT
Title (en)
FACTOR H FRAGMENT FOR USE AS AN ANTI-ANGIOGENIC AGENT
Title (de)
FAKTOR-H-FRAGMENT ZUR VERWENDUNG ALS ANTI-ANGIOGENES MITTEL
Title (fr)
FRAGMENT DU FACTEUR H POUR SON UTILISATION COMME AGENT ANTI-ANGIOGÉNIQUE
Publication
Application
Priority
- FR 1563465 A 20151230
- FR 2016053689 W 20161230
Abstract (en)
[origin: WO2017115059A1] The invention relates to a complement factor H fragment for use in the therapy and/or prophylaxis of a disease involving neovascularization.
IPC 8 full level
A61K 38/17 (2006.01); A61P 9/10 (2006.01); A61P 27/02 (2006.01)
CPC (source: EP US)
A61K 38/1709 (2013.01 - EP); A61K 38/1725 (2013.01 - EP US); A61P 9/10 (2017.12 - EP US); A61P 27/00 (2017.12 - EP); A61P 27/02 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61K 48/0058 (2013.01 - US)
Citation (search report)
See references of WO 2017115059A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2017115059 A1 20170706; EP 3397266 A1 20181107; FR 3046355 A1 20170707; US 2019388506 A1 20191226
DOCDB simple family (application)
FR 2016053689 W 20161230; EP 16829428 A 20161230; FR 1563465 A 20151230; US 201616066963 A 20161230